Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nkarta Inc (NQ: NKTX )

3.080 -0.250 (-7.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Nkarta Inc

< Previous 1 2 3 4 Next >
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Why Nkarta Stock Is Soaring Today
One analyst is now more bullish about this clinical-stage biotech stock. 
Via The Motley Fool
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024
NKTX stock results show that Nkarta beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
NKTX Stock Earnings: Nkarta Beats EPS for Q1 2024
NKTX stock results show that Nkarta beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
These Analysts Revise Their Forecasts On Nkarta After Q4 Results
Nkarta, Inc. (NASDAQ: NKTX) posted a loss for the fourth quarter on Thursday. 
Via Benzinga
3 Undervalued Stocks Primed for a 2X Return
Discover compelling investment opportunities with top undervalued stocks for high returns leading in healthcare and software. 
Via InvestorPlace
Opportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street’s Radar
Explore these undiscovered stock picks attached with rapid growth in biotechnology, oil and gas, and pharmaceuticals. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D... 
Via Benzinga
Nasdaq Turns Higher; Akanda Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures US Equities
NKTX Stock Earnings: Nkarta Beats EPS for Q4 2023
NKTX stock results show that Nkarta beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; US New Home Sales Fall In February
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning. 
Via InvestorPlace
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results. 
Via Benzinga
Stocks Level Off, S&P 500 Nears Best Week Of 2024, NVIDIA Rallies For 11th Week, Bitcoin Sinks: What's Driving Markets Friday?
Stocks slightly retreated during New York’s morning session on Friday, following another robust week of gains fueled by a dovish Federal Reserve meeting, which underscored Chair Jerome Powell‘s... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Is Cancer Drug-Developer Nkarta Stock Trading Lower On Friday?
Nkarta closed patient enrollment in NKX101 clinical trial, reallocating focus to lead program NKX019 for autoimmune disease. Recent expansion into autoimmune disease with FDA clearance for NKX019 in... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line
The company is deprioritizing a key piece of its pipeline in favor of a potential lupus treatment. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
FedEx To Rally Over 32%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
3 Overlooked Stocks Ready to Capture the Market by Storm
Here are three overlooked stocks ready to revolutionize and gear up for tech consulting, wireless telecommunication and biotechnology. 
Via InvestorPlace
3 Silent Tech Titans-in-the-Making: Invest Before They Skyrocket
Unlock the potential of tech sector investments with insights on three stocks poised for remarkable growth in diverse industries. 
Via InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value. 
Via InvestorPlace
3 Under-the-Radar Stocks Set to Soar 300% by 2026
Uncover the potential of three under-the-radar stocks for 300% growth by 2026, spanning tech, biotech and energy sectors. 
Via InvestorPlace
3 Sleeper Stocks With Serious Potential to Make You a Millionaire
Investors might miss these under-the-radar stocks and miss out on gains. Here are three sleeper companies with millionaire potential. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.